Atlas Trials

Expanded Access to OKN-007 for Patients With Diffuse Midline Glioma, H3 K27-altered

Clinical trial NCT05518838 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT05518838
Sponsor
Oblato, Inc.
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Diffuse Midline Glioma, H3 K27M-MutantDiffuse Intrinsic Pontine Glioma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.